[1] Univ Athens, Sch Med, Dept Clin Therapeut, Athens, Greece
[2] Natl & Kapodistrian Univ Athens, Sch Med, Dept Clin Therapeut, Athens, Greece
[3] Hosp Claude Huriez, CHRU Lille, Serv Malad Sang, Lille, France
[4] Hop St Louis, Hematol Dept, Paris, France
[5] Azienda Osped Univ Policlin S Orsola, Bologna, Italy
[6] Univ Barcelona, Amyloidosis & Myeloma Unit, Dept Hematol,Serv Hematol, Hosp Clin Barcelona,IDIBAPS, Barcelona, Spain
[7] Westmead Hosp, Sydney, NSW, Australia
[8] Princess Alexandra Hosp, Brisbane, Qld, Australia
[9] Univ Ostrava, Fac Med, Ostrava, Czech Republic
[10] Nantes Univ Hosp, Dept Hematol, Nantes, France
[11] CHU Limoges, Dept Hematol, Ctr Natl Reference Malad Rares Amylose AL & Autre, Limoges, France
[12] Heidelberg Univ, Heidelberg, Germany
[13] St Vincents Hosp Melbourne, Dept Haematol, Fitzroy, Vic, Australia
[14] Univ Claude Bernard Lyon 1, Oncohematol Ctr Leon Berard, Lyon, France
[15] Sir Charles Gairdner Hosp, Perth, WA, Australia
[16] Univ Hosp Salamanca, IBSAL, Salamanca, Spain
[17] UCL, Natl Amyloidosis Ctr, London, England
[18] Claude Huriez Univ Hosp, Dept Internal Med & Clin Immunol, Lille, France
[19] Fdn IRCCS Policlin San Matteo, Amyloidosis Res & Treatment Ctr, Pavia, Italy
[20] Univ Pavia, Pavia, Italy
[21] Natl & Kapodistrian Univ Athens, Sch Med, Athens, Greece
[22] Hop St Louis, Paris, France
[23] Univ Pavia, Dept Mol Med, Amyloidosis Res & Treatment Ctr, Pavia, Italy
[24] Univ Turin, AOU Citta Salute & Sci, Turin, Italy
[25] Erasmus MC Canc Inst, Dept Hematol, Rotterdam, Netherlands
[26] Aalborg Univ, Dept Clin Med, Aalborg, Denmark